Stocks seemed ready to plunge even farther into record territory after Wednesday��s euphoria.
The market held onto gains despite a rise in jobless claims: Initial unemployment claims were up 15,000 to 309,000 in the week ended Sept. 14; the week prior was also revised upward by 2,000, to 294,000. The numbers remain murky because of backlogs in California and Nevada that might be skewing data.
Nonetheless, the figure came in well below economists�� expectations for 338,000 claims, and unemployment remains near a six-year low.
Elsewhere, investors were still digesting the Federal Reserve��s decisions not to begin pulling back on its $85 billion per month bond-buying program.
While the decision obviously pleased the market, the decision carries its own problems, as investors are once again left wondering when the Fed��s highly accommodative policies will start to wind down��not to mention the implications of a reduced forecast for U.S. economic growth.
��Markets were primed for a reduction, and along with a host of other flashing yellow lights that was enough to make plenty of market watchers cautious, including us,�� wrote Nicholas Colas, chief market strategist at ConvergEx Group.� Yes, the Fed will eventually cut the QE tow rope if/when labor markets improve, but for now they seem content to keep toting the barge and lifting the bale.� That leaves markets free to head to the bar, hopefully avoiding incarceration along the way.� Remember 1999, when markets ripped through Q4 because so many investors had bided their time waiting for the dot-com bubble to collapse earlier in the year?� Cue the music, because this is beginning to look like the same market setup.��
PG&E Corporation, through its subsidiaries, operates as a public utility company that engages in electricity and natural gas distribution primarily in northern and central California. The company also involves in the generation, procurement, transmission, and distribution of electricity; and procurement, transportation, storage, and distribution of natural gas. It owns and operates electricity generation facilities, transmission and distribution lines, and substations; and an integrated natural gas transportation, storage, and distribution system, as well as has underground natural gas storage fields in California. The company serves residential, commercial, industrial, agricultural, public street and highway lighting, and other electric utility customers. As of December 31, 2009, it served approximately 5.1 million electricity distribution customers and approximately 4.3 million natural gas distribution customers. The company also operated 18,650 circuit miles of intercon nected transmission lines and 141,213 circuit miles of distribution lines for electricity; and 42,142 miles of distribution pipelines, 6,438 miles of backbone and local transmission pipelines, and 3 storage facilities for natural gas. PG&E Corporation was founded in 1905 and is based in San Francisco, California.
Advisors' Opinion: Top Managed Healthcare Companies To Own In Right Now: U.S. Energy Corp.(USEG)
U.S. Energy Corp. engages in the acquisition, exploration, holding, sale, and/or development of mineral properties. It primarily explores for molybdenum, and other base and precious metals. The company holds interests in Mount Emmons property that covers approximately 9,311 acres located in Gunnison County, Colorado. It also holds interests in oil and gas properties located in Williston Basin North Dakota and Gulf Coast region. In addition, the company holds interests in geothermal properties. Further, it develops multifamily apartment project in Gillette, Wyoming. As of December 31, 2009, its estimated proved reserves were approximately 1,086,203 BOE. The company was founded in 1966 and is based in Riverton, Wyoming.
Advisors' Opinion: - [By Roberto Pedone]
US Energy (USEG), an independent energy company, focuses on the acquisition and development of oil and gas producing properties in the continental U.S. This stock closed up 6.9% to $3.53 in Thursday's trading session.
Thursday's Range: $3.29-$3.53
52-Week Range: $1.45-$4.06
Thursday's Volume: 116,000
Three-Month Average Volume: 219,710
From a technical perspective, USEG bounced sharply higher here right off some near-term support at $3.27 and back above its 50-day moving average of $3.45 with lighter-than-average volume. This stock recently formed a triple bottom chart pattern at $3.32, $3.21 and $3.27. Since finding buying interest at those levels, shares of USEG are now spiking higher and moving within range of triggering a near-term breakout trade. That trade will hit if USEG manages to take out some near-term overhead resistance levels at $3.65 to $3.80 with high volume.
Traders should now look for long-biased trades in USEG as long as it's trending above some key near-term support levels at $3.27 or at $3.21 and then once it sustains a move or close above those breakout levels with volume that hits near or above 219,710 shares. If that breakout hits soon, then USEG will set up to re-test or possibly take out its 52-week high at $4.06. Any high-volume move above that level will then give USEG a chance to tag its next major overhead resistance levels at $4.60 to $5.
Top Managed Healthcare Companies To Own In Right Now: Osaka Gas Co Ltd (OSA)
OSAKA GAS CO., LTD. is primarily engaged in gas business. It operates in four business segments. The Gas segment is involved in the production, supply and sale of gas, the sale of gas equipment and housing equipment, the construction of gas piping works, the maintenance and inspection of gas equipment. The Liquefied Petroleum Gas (LPG), Electric and Other Energy segment is engaged in the sale of LPG and the supply of electricity. The Oversea Energy segment is engaged in the leasing of liquefied natural gas (LNG) tankers, the oil and gas-related development and investment, the research and investment of energy supply business. The Environment and Non-energy segment is involved in the development, leasing, management and subdivision of real estates, the leasing and maintenance of automobiles, the manufacture and sale of fine materials and carbon materials, the staff dispatching business, the credit and insurance agency business and the operation of sports facilities.
Advisors' Opinion: - [By Damian Illia]
The company is also aware that its ability to sell non-invase treatment products relies largely on the willingness of third parties to pay for treatment. Therefore, it not only focuses on developing devices to treat sleep apnea and other respiratory problem. It also does on increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated SDB as well as educating caregivers about therapy options. It is estimated that SDB affects 20 percent of the adult population and that 90 percent who have obstructed sleep apnea (OSA) still are and most likely will remain undiagnosed and untreated. The company has therefore created a number of foundations and funds primary care physician programs to educate doctors on SDB. On the other hand, diagnosed COPD patients in America are around 12 million people, but is is estimated that another 12 milion may have the disease and hasn't been diagnosed yet. Also, ResMed looks forward to capture those patients who formerly balked at costly, uncomfortable testing in a sleep lad through at-home sleep apnea testing. What this all really means actually, is that ResMed's potential markets have not really been penetrated and that the growth prospects for the coming years is huge.
Top Managed Healthcare Companies To Own In Right Now: Tableau Software Inc (DATA)
Tableau Software, Inc., incorporated on July 19, 2004, is a computer software company. The Company��s products are used by people across all kinds of organizations, including Fortune 500 corporations, small and medium-sized businesses, government agencies, universities, research institutions and non-profits. Organizations employ its products in a range of use cases, such as increasing sales, streamlining operations, improving customer service, managing investments, assessing quality and safety, studying and treating diseases, completing academic research, addressing environmental problems and improving education. The Company��s product helps a single user on a laptop analyze data from a simple spreadsheet, or to enable thousands of users across an enterprise to execute queries against databases.
The Company��s technology includes VizQL and its Hybrid Data Architecture. VizQL, translates drag-and-drop actions into data queries and then expresses that information visually. VizQL unifies the formerly disparate tasks of query and visualization and allows users to transform questions into pictures without the need for software scripts, chart wizards or dialogue boxes that inhibit speed and flexibility. The Company��s Hybrid Data Architecture combines the power and flexibility of its Live Query and In-Memory Data Engines. The Company��s Live Query Engine allows users to instantaneously connect to volumes of data in its existing format and location, reducing the need for time-consuming data transformation processes that only technical specialists can perform. In addition, this capability allows customers to leverage investments in their existing data platforms and to capitalize on the capabilities of high performance databases. The Company��s In-Memory Data Engine enables users to import amounts of data into its own in-memory database.
Advisors' Opinion: - [By Tim Beyers]
Tableau Software (NYSE: DATA ) , one of this year's most exciting new IPOs, burst onto the scene with two straight days of surging stock prices. There's much to like about the business of data visualization, so keep an eye on this stock.
- [By GURUFOCUS]
Tableau Software, Inc. (DATA), a recent IPO, was a strong contributor to performance during the second quarter. Tableau offers proprietary data discovery and visualization tools that help business users analyze and derive insights from business data. Unlike traditional business intelligence platforms, Tableau is intuitive to use, fast to deploy, and can be configured without involving the IT department.We estimate that Tableau serves a market that is in excess of $20 billion annually, or more than 100 times larger than the company's current revenue base, leaving a long runway for growth. (Neal Rosenberg)
Top Managed Healthcare Companies To Own In Right Now: Arrowhead Research Corporation(ARWR)
Arrowhead Research Corporation, a clinical stage nanomedicine company, through its subsidiaries, develops therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. It focuses on the design and development of therapeutic agents for the treatment of cancer and obesity, as well as healing wounded or diseased tissue based on nucleic acid delivery, siRNA chemistry, and tissue targeting intellectual properties. The company?s lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism; and Adipotide, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. It also plans to develop its internal preclinical and clinical pipeline, including RONDEL-enabled siRNA drug candidates, Dynamic Polyconjugate (DPC)-enabled drug candidate development, and the non-siRNA-based anti-obesity drug candidate, Adipotide. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.
Advisors' Opinion: - [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By Bryan Murphy]
If you're looking to get the new trading year started on the right foot, then you may want to keep Celldex Therapeutics, Inc. (NASDAQ:CLDX), EnteroMedics Inc. (NASDAQ:ETRM), and Arrowhead Research Corp. (NASDAQ:ARWR) in your back pocket if not in your portfolio. Why? Because these three small cap stocks are positioned to deliver big breakouts, if they're not already doing so. Here's a closer look at each, and exactly what you need to watch for with CLDX, ARWR, and ETRM.
- [By Todd Campbell]
It was all a bit of miscommunication. Or at least that's the spin Arrowhead Research's (NASDAQ: ARWR ) �C-suite is putting on the 50% drubbing its shares suffered last week following the release of data on its ARC-520, a promising therapy for hepatitis B.
Top Managed Healthcare Companies To Own In Right Now: Harmonic Inc.(HLIT)
Harmonic Inc. designs, manufactures, and sells video infrastructure products and system solutions to create, prepare, and deliver a range of video services for television and media platforms in the united States and internationally. Its products include video production platforms and playout solutions, such as video servers used by broadcasters, content owners, and multi-channel network operators to create and play-to-air television channels; video-optimized storage, which provides storage capacity and access bandwidth to support media production applications comprising video editing, content transformation, and media library management; and media applications that provide media integrated management and workflow control over content stored on its systems. The company offers video processing products, including broadcast encoders; contribution and distribution encoders; stream processing and statistical multiplexing solutions; content preparation and delivery for multi-scr een applications; decoders and descramblers; and management and control software. It also provides edge products that integrate routing, multiplexing, scrambling, and modulation into a single package; optical transmitters and amplifiers, which operates at various optical wavelengths and serves long-haul and local transport applications in the cable distribution network; optical nodes to supports network architectures for bandwidth delivered to a service area; and return path transmitters that support two-way transmission capabilities for analog or digital transport. In addition, the company offers technical support and professional services, such as maintenance and support; and consulting, implementation, and integration services. Harmonic Inc. sells its products through direct sales force, independent distributors, and integrators to cable, satellite and telco, and broadcast and media companies. The company was founded in 1988 and is headquartered in San Jose, California. Advisors' Opinion:
- [By Lee Jackson]
Harmonic Inc. (NASDAQ: HLIT) is a top small cap name to buy at Oppenheimer. Revenue in the second quarter totaled $117.1 million, and bookings were $126.3 million. Non-GAAP net income was $5.6 million, or $0.05 per share. That bottom-line result is a welcome improvement compared to the adjusted net loss of $0.02 per share a year ago. The stock was up as much as 16% after earnings, and it may be a top name to own for the rest of the year. The consensus price target for the stock is $7.
